What the company does
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma …
What the weekly tape is saying
ABBV34 closed the latest completed week at 71.90 BRL. The 4-week return is 7.7% and the 12-week return is 8.1%. Trend Signal is inactive, Market Dynamics is 0.08. Setup signature: Balanced read with a 43/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 71.27 BRL
- Vs Trend Line
- 0.9%
- Fair Value
- 60.49 BRL
- Vs Fair Value
- 18.9%
- 52W High
- 80.06 BRL
- 52W Low
- 58.81 BRL
- Drawdown
- -10.2%
- Range Position
- 61.6%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 19
- 52W Active Breadth
- 36.5%
- Sector Scope
- BR Healthcare
- Sector Rank
- 63 of 80
- Sector Percentile
- 21.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
BR Healthcare
- Tracked Peers
- 80
- 4W Rank
- 25 of 80
- Avg 1W
- 1.2%
- Avg 4W
- 3.5%
- Trend Breadth
- 20.0%
- Positive MD
- 31.3%
BR Drug Manufacturers - General
- Tracked Peers
- 13
- 4W Rank
- 3 of 13
- Avg 1W
- 0.2%
- Avg 4W
- 3.2%
- Trend Breadth
- 7.7%
- Positive RS
- 46.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.08
- 4W MD Change
- 108.8%
- Relative Strength
- -5.40
- 4W RS Change
- 66.4%
- Expectation
- Undecided
- Probability
- 52.22%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.8K
- 13W Average
- 9.1K
- 52W Average
- 10.8K
- Vs 13W
- 0.2x
- Vs 52W
- 0.2x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 5.6%
- 52W Volatility
- 4.1%
- Upside Weeks
- 26
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 3.3% / -2.8%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- SAO
- Country
- BR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- BRL
- Market Cap
- 1887.5B
Opportunity signals
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Recent volatility is running well above the one-year baseline.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 71.90 BRL | -1.8% | 71.27 BRL | 60.49 BRL | 0.08 | -5.40 | 1.8K | Off |
| 5 Jun 2026 | 73.23 BRL | 6.8% | 71.22 BRL | 60.28 BRL | -0.22 | -2.66 | 3.1K | Off |
| 29 May 2026 | 68.54 BRL | 1.4% | 71.19 BRL | 60.06 BRL | -0.55 | -11.56 | 1.3K | Off |
| 22 May 2026 | 67.62 BRL | 1.3% | 71.47 BRL | 59.87 BRL | -0.66 | -14.24 | 4.3K | Off |
| 15 May 2026 | 66.78 BRL | 7.7% | 71.74 BRL | 59.69 BRL | -0.86 | -16.07 | 7.8K | Off |
| 8 May 2026 | 61.98 BRL | -8.9% | 72.01 BRL | 59.53 BRL | -1.03 | -25.24 | 58.9K | Off |
| 1 May 2026 | 68.00 BRL | 10.0% | 72.53 BRL | 59.40 BRL | -1.14 | -19.82 | 7.2K | Off |
| 24 Apr 2026 | 61.83 BRL | -4.8% | 72.82 BRL | 59.24 BRL | -1.24 | -28.86 | 3.4K | Off |
| 17 Apr 2026 | 64.98 BRL | -0.2% | 73.16 BRL | 59.12 BRL | -1.24 | -27.61 | 3.0K | Off |
| 10 Apr 2026 | 65.09 BRL | -2.3% | 73.41 BRL | 59.01 BRL | -1.25 | -28.51 | 10.9K | Off |
| 3 Apr 2026 | 66.64 BRL | -2.2% | 73.66 BRL | 58.89 BRL | -1.17 | -23.69 | 12.3K | Off |
| 27 Mar 2026 | 68.13 BRL | 2.4% | 73.79 BRL | 58.76 BRL | -0.95 | -19.74 | 788 | Off |
| 20 Mar 2026 | 66.52 BRL | -8.3% | 73.88 BRL | 58.62 BRL | -0.91 | -19.82 | 3.9K | Off |
| 13 Mar 2026 | 72.58 BRL | -2.9% | 74.01 BRL | 58.50 BRL | -0.80 | -13.83 | 10.4K | Off |